Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Short Title Phase 3 Sonrotoclax + Zanubrutinib compared with Ven + Obinutuzumab in Patients untreated CLL
Clinical Trial Grant
Duke Scholars
Principal Investigator
Danielle Marie Brander
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
BeiGene USA, Inc.
Start Date
May 21, 2024
End Date
April 30, 2029
Awarded By
BeiGene USA, Inc.
Start Date
May 21, 2024
End Date
April 30, 2029
